Mydecine Signs LOI with The Newly Institute to Provide Psychedelic-Assisted Psychotherapy to Patients under Health… Jan 18, 2022
Mydecine to Launch Special Access Support and Supply Program in Canada Expanding Access to Psychedelic-Assisted… Jan 13, 2022
Mydecine Achieves Innovative Supercomputing Artificial Intelligence Modeling in Psychedelic Drug Development Enabling… Jan 10, 2022
Mydecine Files Full Patent Application Covering New Formulations that Bring Nanoemulsion Technology to Traditional… Nov 3, 2021
Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Part of Psychedelic Medicine Research Renaissance Nov 2, 2021